作者
Francesco Baratta, Daniele Pastori, Francesco Angelico, Andrea Balla, Alessandro Maria Paganini, Nicholas Cocomello, Domenico Ferro, Francesco Violi, Arun J Sanyal, Maria Del Ben
发表日期
2020/9/1
期刊
Clinical Gastroenterology and Hepatology
卷号
18
期号
10
页码范围
2324-2331. e4
出版商
WB Saunders
简介
Background & Aims
Patients with non-alcoholic fatty liver disease (NAFLD) are at increased chance for cardiovascular events (CVEs). Severity of liver fibrosis is used to determine prognoses for patients with NAFLD, but little is known about the relationship between liver fibrosis and CVEs in the real world.
Methods
We analyzed data from the prospective observational progression of liver damage and cardiometabolic disorders in non-alcoholic fatty liver disease study, comprising 898 consecutive outpatients (mean age, 56.4 ± 12.7 years; 37.5% women) screened for liver steatosis by ultrasound according to Hamagughi criteria. Liver fibrosis was defined as FIB-4 score greater than 2.67 and NAFLD fibrosis score greater than 0.676. After enrolment, patients were interviewed by phone every 6 months and examined every 12 months in the outpatient clinic, and CVEs were recorded (fatal or nonfatal ischemic stroke and …
引用总数
学术搜索中的文章